JCU (4975) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
10 Dec, 2025Executive summary
Net sales rose 17.2% year-over-year to ¥12,736 million for 1H FY3/25, with operating profit up 50.7% and profit attributable to owners of parent up 55.5%.
Recovery in electronics and semiconductor markets in China, Taiwan, and South Korea drove chemicals sales growth, while Japan saw a decline due to design trend changes.
Machine business sales increased as projects progressed, but new large project orders and backlog declined.
The company launched a new medium-term management plan, “JCU VISION 2035-1st stage-,” focusing on growth markets, DX, and sustainability.
Financial highlights
Net sales for 1H FY3/25 were ¥12,736 million, up 17.2% year-over-year; operating profit ¥4,665 million, ordinary profit ¥4,983 million, and net income per share ¥133.72.
Gross profit margin improved as gross profit rose to ¥8,615 million from ¥6,582 million a year earlier.
Profit attributable to owners of parent was ¥3,385 million, up 55.5% year-over-year.
Cash and cash equivalents increased by ¥3,823 million to ¥28,410 million at period end.
Outlook and guidance
Full-year FY3/25 forecasts: net sales ¥27,000 million, operating profit ¥8,500 million, ordinary profit ¥8,500 million, profit attributable to owners of parent ¥5,900 million, and EPS ¥232.90.
Progress rates against full-year forecasts: net sales 47.2%, operating profit 54.9%, ordinary profit 58.6%, profit attributable to owners of parent 57.4%.
No revisions to previously announced forecasts; management expects continued demand growth in electronics, especially for PWBs and semiconductor substrates.
Latest events from JCU
- Profits and sales rose, with higher full-year and dividend forecasts.4975
Q3 20265 Feb 2026 - Strong profit and sales growth, share buyback, and positive full-year outlook.4975
Q1 202510 Dec 2025 - Profits and sales soared on Asian electronics recovery, prompting an upward outlook revision.4975
Q3 202510 Dec 2025 - Double-digit profit growth, higher dividends, and stable FY2026 outlook with currency risk.4975
Q4 202510 Dec 2025 - Strong 1Q profit growth and solid progress toward annual targets, led by chemicals.4975
Q1 202610 Dec 2025 - Strong 1H FY3/26 growth in sales and profit, with positive outlook and higher dividends.4975
Q2 202610 Dec 2025